Jennifer Dally

Director CMC Analytical Project Leadership at GSK

Role
Director Biopharmaceutical Analytical Project Leadership at GSK
Location
Philadelphia, PA, US
LinkedIn followers
500 followers

About Jennifer Dally

GlaxoSmithKline (GSK) is a science-led, global healthcare company that researches and develops innovative products. GSK currently employ over people globally and has offices in more than 115 countries. At GSK, our mission is to improve the quality of human life by enabling people to do more, feel better, live longer. We need a talented, motivated and resilient workforce if we are to deliver against our strategy and tackle global health challenges effectively. To achieve this, we aim to create a working environment where employees feel valued, respected, empowered and inspired. R&D innovation underpins all of our businesses. We partner with more than 1,500 other companies and academic organizations around the world, enabling us to increase our understanding of new areas of science and to share the risk of development. We have a deep portfolio of innovation focused across six core areas of scientific research and development: HIV and infectious diseases, oncology, immuno-inflammation, vaccines, respiratory and rare diseases. Personally, I have more than 20 years of experience in leading R&D and commercial analytical development projects and have demonstrated expertise in QbD approaches to analytical lifecycle management, new platform technology development, analytical method development and validation, and regulatory strategy. My current role is Director of Biopharmaceutical Analytical Project Leadership which has afforded me the opportunity to provide scientific and operational leadership to CMC project teams for development and delivery of stage appropriate analytical strategies for Biopharmaceuticals.

Experience

  1. Director Biopharmaceutical Analytical Project Leadership

    GSK

    Jan 2018 — Present · King of Prussia, PA, US

    Built and implemented the Analytical Work Stream department (Analytical Project Leadership) within the Biopharmaceutical Development organization. Lead a team responsible for providing scientific and operational leadership to CMC project teams for development and delivery of stage appropriate analytical strategies for biopharmaceuticals. Manage interactions with CMO/ CRO for manufacturing and testing of clinical and commercial launch materials, analytical technology transfer and validation approaches, continuous assay performance monitoring, product characterization and CMC support for regulatory filings and agency interactions including US, EU, CA, JP and emerging markets. Lead the overall analytical lifecycle of products through implementation of QbD approaches including assessing the relationship among Quality Target Profile, Critical Quality Attributes, Critical Process Parameters, and Testing Strategy.

Education

  • University of the Sciences in Philadelphia

    Doctor of Philosophy (Ph.D.), Analytical Chemistry

    1998 — 2007

  • Philadelphia. College of Pharmacy and Science

    Bachelor's Degree, Chemistry

    1993 — 1997

Skills

  • Gmp
  • Biopharmaceuticals
  • Biotechnology
  • Good Laboratory Practice (Glp)
  • Life Sciences

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Jennifer Dally — Director Biopharmaceutical Analytical Project Leadership at GSK in Philadelphia, PA, US | Unifers